{'fraction_non_alphanumeric': 0.019659239842726082, 'fraction_numerical': 0.005242463958060288, 'mean_word_length': 5.643478260869565, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries?

A considerable effort has been made to summarize current knowledge concerning the evaluation, prognosis and management of variceal development and its consequences [1 5]. These have mostly been supplementary, offering updated guidelines based on the newest meta-analyses at the time [6 9]. The intention of this document is not to produce another set of guidelines, but to update and summarize the current guidelines in relation to current practice and patient population and therapeutic tradition in the Nordic countries, and to relate these to the newer treatment modalities such as prophylactic antibiotics and transjugular intrahepatic portosystemic shunt (TIPS).